Business
Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023
BURLINGTON, Mass., Aug. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS MedTech,
About this update from Azenta, Inc.
[{"type":"text","content":"BURLINGTON, Mass., Aug. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the UBS MedTech, Tools and Genomics Summit 2023 in Dana Point, CA, on Tuesday, August 15, 2023, which includes a presentation beginning at 3:00 pm PT. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.\nAbout Azenta Life Sciences\nAzenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.\nAzenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.\nINVESTOR CONTACTS:Sara SilvermanHead of Investor Relations & Corporate [email protected]\nSherry [email protected]\n\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-ubs-medtech-tools-and-genomics-summit-2023-301897289.html\nSOURCE Azenta","length":3308,"tagName":"div"}]